Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Zai Lab Ltd ( (HK:9688) ).
Zai Lab Limited announced the filing of its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, with the U.S. Securities and Exchange Commission. This filing is part of the company’s regulatory compliance and provides stakeholders with updated financial and operational information, potentially impacting its market positioning and investor relations.
More about Zai Lab Ltd
Zai Lab Limited is a biopharmaceutical company incorporated in the Cayman Islands, focusing on developing and commercializing innovative medicines. The company operates in the healthcare industry, with a market focus on addressing significant unmet medical needs in oncology, autoimmune, and infectious diseases.
Average Trading Volume: 8,916,837
Technical Sentiment Signal: Buy
Current Market Cap: HK$26.04B
Learn more about 9688 stock on TipRanks’ Stock Analysis page.